Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes

Diabetic nephropathy (DN) is one of the most perilous side effects of diabetes mellitus type 1 and type 2 (T1DM and T2DM).). It is known that sodium/glucose cotransporter 2 inhibitors (SGLT 2i) and glucagone like peptide-1 receptor agonists (GLP-1 RAs) have renoprotective effects, but the molecular...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Sci
Main Authors: Ninčević, Vjera, Omanović Kolarić, Tea, Roguljić, Hrvoje, Kizivat, Tomislav, Smolić, Martina, Bilić Ćurčić, Ines
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6928920/
https://ncbi.nlm.nih.gov/pubmed/31757028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20235831
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki